Home › Funds › Deep Track Capital, LP › ALNY

Deep Track Capital, LP position in ALNY

ALNYLAM PHARMACEUTICALS INC · Health Care

Deep Track Capital, LP reported holding 825,000 shares of ALNY (ALNYLAM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$248.3M, representing 3.70% of its reported portfolio and ranking #5 among its reported holdings. Deep Track Capital, LP has disclosed ALNY holdings in 3 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)825.00K sh
Reported value held$248.35M
Portfolio Weight3.70%
First reportedQ1 2024
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Deep Track Capital, LP's ALNY position evolved

Deep Track Capital, LP first disclosed a stake in ALNY in Q1 2024 at 832,310 shares (US$124.4M). The position peaked in Q2 2026 at 825,000 shares, worth US$248.3M. Across 3 filings, Deep Track Capital, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 825,000 shares valued at US$248.3M. Notable position changes include a 40% trim in Q2 2024 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 832.31K $124.39M New
Q2 2024 500.00K $121.50M Reduce
Q2 2026 825.00K $248.35M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ALNY and 13F data

ALNY (ALNYLAM PHARMACEUTICALS INC) is a Health Care company. 35 other funds we track also report a position in ALNY — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.70B), Baillie Gifford & Co (US$734.5M), Orbis Allan Gray Ltd (US$598.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ALNY

All ALNY fund holders →

FAQ

How long has Deep Track Capital, LP held ALNY?

Deep Track Capital, LP has disclosed ALNY holdings in 3 of the last 10 reported quarters, going back to Q1 2024.

What is Deep Track Capital, LP's current position in ALNY?

As of Q2 2026, Deep Track Capital, LP holds 825.00K shares of ALNY (ALNYLAM PHARMACEUTICALS INC), valued at $248.35M, representing 3.70% of its reported portfolio and ranking #5.

Has Deep Track Capital, LP been buying or selling ALNY?

In the latest 13F filing (Q2 2026), Deep Track Capital, LP newly opened its position in ALNY. The position peaked in Q2 2026 at 825.00K shares.

Which other funds hold ALNY?

Other major institutional holders of ALNY include T. Rowe Price Investment Management, Inc., Baillie Gifford & Co, Orbis Allan Gray Ltd, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.